 |
 | |||||||||
| |||||||||
|
| |||||||||
| |||||||||
| US biomedical company sets up base in Hong Kong ( 09/02/2004 ) | |||||||||
The president of MedWaves Inc, Dr George Leung, explained the reasons for setting up a base in Hong Kong. "The quality of the people, the resources, and the location were the primary factors that led us to select Hong Kong to be the base for development and commercialisation of our microwave catheter ablation system in Asia. We are extremely impressed with the work ethic and quality of work here. Hong Kong has a wealth of talented technical and marketing professionals who can readily adjust to new technology," said Dr Leung. "Being located in the centre of Asia, with strong financial and manufacturing infrastructures, Hong Kong is an excellent location to facilitate the production and distribution of our products," he added. MedWaves Inc's chief operating officer Dr Ming-Fan Law said it is Hong Kong's world-class medical expertise which draws the company to the SAR. "We are in the business of providing cures for heart rhythm abnormalities. Hong Kong has world-class cardiologists and electrophysiologists that are essential for MedWaves Hong Kong to successfully conduct and complete its pre-clinical and clinical studies in Asia." Mike Rowse, director general of investment promotion at InvestHK, a government department tasked with attracting and retaining overseas investment to Hong Kong said MedWaves' presence underscores Hong Kong's "excellent business environment for biotechnology companies." Related links | |||||||||
| |||||||||
|
|
